Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
In mid-2007, Pharmalucence was created via the management buy-out of CIS-US by three long-term employees who shared the vision to become both an advanced contract manufacturing organization (CMO) and a leading manufacturer of radiopharmaceuticals.
Pharmalucence received approval of its first new product, the hepatobiliary imaging agent generic Mebrofenin, in 2008.
In July 2009, Pharmalucence received approval for its generic Sestamibi, an agent used in millions of myocardial perfusion imaging studies annually.
In 2012 Pharmalucence moved into a new manufacturing facility and company headquarters in Billerica MA.
On July 15, 2014, Pharmalucence was acquired by Sun Pharmaceuticals.
On April 25, 2016, Pharmalucence received FDA approval to begin manufacturing operations at its new Billerica MA facility.
On April 1st, 2020 Pharmalucence became fully integrated into Sun Pharmaceutical Industries Inc.
Rate how well Pharmalucence lives up to its initial vision.
Do you work at Pharmalucence?
Is Pharmalucence's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Acusphere | 1993 | - | 118 | - |
| DURECT | 1998 | $2.0M | 88 | - |
| Supernus Pharmaceuticals | 2005 | $661.8M | 448 | 40 |
| Eagle Pharmaceuticals | 2007 | $316.6M | 96 | 3 |
| EyeGate Pharmaceuticals | 1998 | $767,000 | 30 | - |
| Xttrium Laboratories | 1932 | $18.0M | 83 | - |
| Cassava Sciences | 1998 | $41.1M | 24 | 1 |
| Mikart | 1975 | $48.0M | 3 | 4 |
| Denison Pharmaceuticals | - | $75.0M | 100 | - |
| Hemispherx Biopharma, Inc. | 1990 | $335,000 | 33 | - |
Zippia gives an in-depth look into the details of Pharmalucence, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Pharmalucence. The employee data is based on information from people who have self-reported their past or current employments at Pharmalucence. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Pharmalucence. The data presented on this page does not represent the view of Pharmalucence and its employees or that of Zippia.
Pharmalucence may also be known as or be related to Pharmalucence and Pharmalucence, Inc.